FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2013/05/003658 [Registered on: 21/05/2013] Trial Registered Retrospectively
Last Modified On: 18/05/2013
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Probiotic
Preventive 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A clinical trial to study the effectiveness of probiotics in lower reproductive tract infections in women. 
Scientific Title of Study   Effectiveness of probiotics in lower reproductive tract infection in women of age group 18 to 45 years.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
probiotics  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rukshana Shamshu 
Designation  Junior Resident 
Affiliation  Sree Avittom Thirunal Hospital,MCH,Thiruvananthapuram 
Address  Ecstacy, C.T.Junction,T.K.M.C. P.O.,Karickode,Kollam
Department of Obstetrics and Gynaecology,SATH,MCH,TVM
Thiruvananthapuram
KERALA
691005
India 
Phone  9495703495  
Fax    
Email  rukshanaimtyaz@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr C NIRMALA 
Designation  Professor & HOD 
Affiliation   
Address  Department of Obstetrics and Gynaecology,SAT Hospital, Medical College,Thiruvanathapuram

Thiruvananthapuram
KERALA
695011
India 
Phone  9447047886  
Fax    
Email  trogstvpm@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Jayasree Vaman 
Designation  Additional Professor of Obstetrics and Gynaecology, T.D. Medical College, Vanadanam, Alappuzha 
Affiliation   
Address  Uthram, Opp. Petrol pump, Kochulloor, Medical college P.O., Thiruvananthapuram, Kerala

Thiruvananthapuram
KERALA
695011
India 
Phone  9447697850  
Fax    
Email  jysree@gmail.com  
 
Source of Monetary or Material Support  
Dr. Rukshana Shamshu, Department of Obstetrics & Gynaecology, Sree Avittom Thirunal Hospital (SATH), Medical College, Thiruvananthapuram, Thiruvananthapuram - 695011 KERALA  
 
Primary Sponsor  
Name  Dr Rukshana Shamshu 
Address  Ecstacy,C.T. Junction,T.K.M.C P.O, Karickode, Kollam 691005 (Department of Obstetrics & Gynaecology, Sree Avittom Thirunal Hospital (SATH), Medical College, Thiruvananthapuram, Thiruvananthapuram - 695011 KERALA) 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rukshana Shamshu  OPD of Obstetrics & Gynaecology,Sree Avittom Thirunal Hospital (SATH)  Out Patient Department (OPD) of Obstetrics & Gynaecology, Room No. 134, Sree Avittom Thirunal Hospital (SATH), Medical College, Thiruvananthapuram - 695011, Kerala
Thiruvananthapuram
KERALA 
9495703495

rukshanaimtyaz@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Human Ethics Committee ,Govt. Medical College, Thiruvananthapuram  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Women with complaints of abnormal vaginal discharge suggestive of bacterial vaginosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Tab Metronidazole and placebo  500mg 1-1-1 for 7 days for Metronidazole and two capsules per day for thirty days - placebo 
Intervention  Tab metronidazole and Probiotic capsule containig more than one million bacilli each of Lactobacillus Rhamnosus GR-I and Lactobacillus Reuteri RC-14  Tab metronidazole 500 mg 1-1-1 for 7 days and placebo 2 capsules per day for thirty days to the study group.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Women between 18 and 45 years attending gynaecology OPD with complaint vaginal discharge and/or vaginal itching who gives informed consent. 
 
ExclusionCriteria 
Details  1. Women of below 18 years and above 45 years age group.
2. Women with history of diabetes mellitus.
3. Women with malignancy or those on cancer chemotherapy.
4. Women with chroic liver disease,chroic renal disease.
5. Women with HIV infection and those on immunosuppressive therapy.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Assess the effectiveness of the probiotic strains having Lactobacillus rhamnosus GR -1 and Lactobacillus reuteri RC-14 in the management of lower genital infections(bacterial vaginosis as an integral therapy with antibiotics.  one year 
 
Secondary Outcome  
Outcome  TimePoints 
Assess the effectiveness of probiotics in maintaining a healthy genital flora throughout the treatment period  one year 
 
Target Sample Size   Total Sample Size="42"
Sample Size from India="42" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/01/2012 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

In the SAT gynaecology OPD, 40 to 50% women present with vaginal discharge .24.7% of them have a flora suggestive of bacterial vaginosis.Incidence of HIV and STD are on an increase.

Bacterial Vaginosis has been found to be associated with preterm labour, PROM, postpartum endometritis, puerperal and post abortion sepsis which can be prevented by early treatment. it is also associated with post operative infectios ad vaginal cuff cellulitis.

To avoid the rising rates of antibiotic resistance, following use in lower reproductive tract infection the role of probiotics has been considered as a means of protection against lower reproductive tract infection.

Studies have proven the efficacy of probiotics in lower reproductive tract infectio in women.

Hence the significance of this study.

 
Close